Published April 12, 2020 | Version v1
Journal article Open

Medical truths about the appropriate prescription of inhibitors of the proton pump, in hospitalization and external consultation, of two health institutions Bogotá and Cartagena, during the year 2019

Authors/Creators

  • 1. ROR icon Pontificia Universidad Javeriana

Files

251-525-1-PB.pdf

Files (487.7 kB)

Name Size Download all
md5:175c41d3e6eedd1167afa997967bed67
487.7 kB Preview Download

Additional details

Identifiers

URL
http://eduneuro.com/revista/index.php/revistaneuronum/article/view/251

Dates

Accepted
2020-04-12

References

  • M Michael W. Proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders. UpToDate.[internet]. 2017 [ citado Dic 2019] ;21(1). Disponible en: Proton pump inhibitors: Overview of use and adverse effects in the treatment of acid related disorders.
  • Ganser AL, Forte JG. K+-stimulated ATPase in purified microsomes of bullfrog oxyntic cells. .[internet].Vol. 307. 25 Abril 1973. Acta 307, 169180 ;ScienceDirect.ElServier. [ citado Noviembre 2019]. Disponible en : 10.1016 / 0005-2736 (73) 90035-7.
  • Julio P, Juan V. Rational the use of PPIs: An unresolved matter. Revista Española de Enfermedaddes Digestivas. Scielo.[internet].2013. Vol.105 Madrid. [ Citado 20 Octubre 2019].Disponible en : http://dx.doi.org/10.4321/S1130-01082013000300001
  • Bruce K, Daniel E, Tumor necrosis factor -alpha inhibitors : An overview of adverse effects [internet]. Uptodate. 2019. [ Citado 11 Noviembre 2019] Disponible en: Tumor necrosis factor-alpha inhibitors: An overview of adverse effects.